Kuntz Richard
SEC CIK 1341125 · EDGAR
Most active insiders at INVE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Newquist Kirsten F. | CEO, Dir | — | — |
| 2 | Angelini Laura | Dir | — | — |
| 3 | KREMEN GARY | Dir | — | — |
| 4 | LOPEZ MIGUEL A | Dir | — | — |
| 5 | Kuntz Richard | Dir | — | — |
| 6 | KIRNBAUER EDWARD | See Remarks | — | — |
| 7 | OUSLEY JAMES E | Dir | — | — |
Transactions 10
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-03 18:47 | 2026-07-30 | INVE | INVE Technologies, Inc. | Kuntz Richard | Dir | A - Grant | $0.00 | +17.5K | 65.7K | +36% | $0 | |
| 2025-07-31 | 2025-07-29 | INVE | INVE Technologies, Inc. | Kuntz Richard | Dir | A - Grant | $0.00 | +21.1K | 48.2K | +78% | $0 | |
| 2025-01-03 | 2025-01-02 | DMAC | DiaMedica Therapeutics Inc. | Kuntz Richard | Dir | A - Grant | $5.34 | +9,925 | 24.2K | +69% | +$53.0K | |
| 2024-10-23 | 2024-07-29 | INVE | INVE Technologies, Inc. | Kuntz Richard | Dir | A - Grant | $0.00 | +14.8K | 27.0K | +121% | $0 | |
| 2024-01-02 | 2024-01-02 | DMAC | DiaMedica Therapeutics Inc. | Kuntz Richard | Dir | A - Grant | $2.80 | +14.3K | 14.3K | New | +$40.0K | |
| 2023-08-02 | 2023-08-01 | INVE | INVE Technologies, Inc. | Kuntz Richard | Dir | A - Grant | $0.00 | +8,904 | 12.2K | +266% | $0 | |
| 2022-11-02 | 2022-10-31 | INVE | INVE Technologies, Inc. | Kuntz Richard | Dir | A - Grant | $0.00 | +3,343 | 3,343 | New | $0 | |
| 2021-11-09 | 2021-11-05 | MDT | Medtronic | Kuntz Richard | SVP, Chief Medical, Science | F - Tax | $122.98 | -209 | 74.9K | -0.3% | -$25.7K | |
| D | 2021-08-04 | 2021-08-02 | MDT | Medtronic | Kuntz Richard | SVP, Chief Medical, Science | A - Grant | $0.00 | +5,029 | 74.9K | +7% | $0 |
| D | 2021-08-04 | 2021-08-02 | MDT | Medtronic | Kuntz Richard | SVP, Chief Medical, Science | F - Tax | $131.31 | -4,905 | 69.9K | -7% | -$644.1K |
Purchase Sale Sale after option exercise All abbreviations